Experimental: CD07223 1.5 % Topical Gel BID

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Impetigo

Drug Information

Target Indication

Impetigo

Clinical Trial

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

NBY

NovaBay Pharmaceuticals, Inc.

Related Pipeline

Impetigo

Bacterial Conjunctivitis

Adenoviral Conjunctivitis

Asymptomatic Bacteriuria

Urinary Catheter Blockage and Encrustation